🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

KRKA, d.d., Novo mesto — Licensed Medicines

361 medicines held by KRKA, d.d., Novo mesto on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 361 products held by KRKA, d.d., Novo mesto
MedicineActive substanceLicence holderStatus
Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Krka 20 mg/5 mg/12.5 mg film-coated tablets
PA1347/096/001
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide KRKA, d.d., Novo mesto Not marketed
Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Krka 40 mg/10 mg/12.5 mg film-coated tablets
PA1347/096/004
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide KRKA, d.d., Novo mesto Not marketed
Olmesartan/Amlodipine Krka 20 mg/5 mg film-coated tablets
PA1347/075/001
Olmesartan medoxomil, Amlodipine KRKA, d.d., Novo mesto Marketed
Olmesartan/Amlodipine Krka 40 mg/10 mg film-coated tablets
PA1347/075/003
Olmesartan medoxomil, Amlodipine KRKA, d.d., Novo mesto Marketed
Olmesartan/Amlodipine Krka 40 mg/5 mg film-coated tablets
PA1347/075/002
Olmesartan medoxomil, Amlodipine KRKA, d.d., Novo mesto Marketed
Olmesartan/Hydrochlorothiazide Krka 20 mg/12.5 mg film-coated tablets
PA1347/061/001
Olmesartan medoxomil, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Olmesartan/Hydrochlorothiazide Krka 20 mg/25 mg film-coated tablets
PA1347/061/002
Olmesartan medoxomil, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Olmesartan/Hydrochlorothiazide Krka 40 mg/12.5 mg film-coated tablets
PA1347/061/003
Olmesartan medoxomil, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Olmesartan/Hydrochlorothiazide Krka 40 mg/25 mg film-coated tablets
PA1347/061/004
Olmesartan medoxomil, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Oprymea 0.088 mg tablets
EU/1/08/469/1-5
Pramipexole KRKA, d.d., Novo mesto
Oprymea 0.18 mg tablets
EU/1/08/469/6-10
Pramipexole KRKA, d.d., Novo mesto
Oprymea 0.26 mg prolonged-release tablets
EU/1/08/469/026-029
Pramipexole KRKA, d.d., Novo mesto
Oprymea 0.35 mg tablets
EU/1/08/469/11-15
Pramipexole KRKA, d.d., Novo mesto
Oprymea 0.52 mg prolonged-release tablets
EU/1/08/469/030-033
Pramipexole KRKA, d.d., Novo mesto
Oprymea 0.7 mg tablets
EU/1/08/469/16-20
Pramipexole KRKA, d.d., Novo mesto
Oprymea 1.05 mg prolonged-release tablets
EU/1/08/469/034-037
Pramipexole KRKA, d.d., Novo mesto
Oprymea 1.1 mg tablets
EU/1/08/469/21-25
Pramipexole KRKA, d.d., Novo mesto
Oprymea 1.57 mg prolonged-release tablets
EU/1/08/469/038-041
Pramipexole KRKA, d.d., Novo mesto
Oprymea 2.1 mg prolonged-release tablets
EU/1/08/469/042-045
Pramipexole KRKA, d.d., Novo mesto
Oprymea 2.62 mg prolonged-release tablets
EU/1/08/469/046-049
Pramipexole dihydrochloride monohydrate KRKA, d.d., Novo mesto
Oprymea 3.15 mg prolonged-release tablets
EU/1/08/469/050-053
Pramipexole dihydrochloride monohydrate KRKA, d.d., Novo mesto
Paglitaz
EU/1/11/721/001-007
Pioglitazone hydrochloride KRKA, d.d., Novo mesto
Paglitaz
EU/1/11/721/008-014
Pioglitazone hydrochloride KRKA, d.d., Novo mesto
Paglitaz
EU/1/11/721/015-021
Pioglitazone hydrochloride KRKA, d.d., Novo mesto
Paliperidone Krka 3 mg prolonged-release tablets
PA1347/092/001
Paliperidone KRKA, d.d., Novo mesto Marketed
Paliperidone Krka 6 mg prolonged-release tablets
PA1347/092/002
Paliperidone KRKA, d.d., Novo mesto Marketed
Paliperidone Krka 9 mg prolonged-release tablets
PA1347/092/003
Paliperidone KRKA, d.d., Novo mesto Marketed
Paracetamol Krka 500 mg tablets
PA1347/095/001
Paracetamol KRKA, d.d., Novo mesto Not marketed
Perindopril arginine/Indapamide/Amlodipine Krka 10 mg/2.5 mg/10 mg tablets
PA1347/112/003
Perindopril arginine, Indapamide, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril arginine/Indapamide/Amlodipine Krka 10 mg/2.5 mg/5 mg tablets
PA1347/112/002
Perindopril arginine, Indapamide, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril arginine/Indapamide/Amlodipine Krka 5 mg/1.25 mg/5 mg tablets
PA1347/112/001
Perindopril arginine, Indapamide, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril Krka 2 mg tablets
PA1347/041/001
Perindopril tert-butylamine KRKA, d.d., Novo mesto Marketed
Perindopril Krka 4 mg tablets
PA1347/041/002
Perindopril tert-butylamine KRKA, d.d., Novo mesto Marketed
Perindopril Krka 8 mg tablets
PA1347/041/003
Perindopril tert-butylamine KRKA, d.d., Novo mesto Marketed
Perindopril/amlodipine Krka 4 mg/10 mg tablets
PA1347/084/002
Perindopril tert-butylamine, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril/amlodipine Krka 4 mg/5 mg tablets
PA1347/084/001
Perindopril tert-butylamine, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril/amlodipine Krka 8 mg/10 mg tablets
PA1347/084/004
Perindopril tert-butylamine, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril/amlodipine Krka 8 mg/5 mg tablets
PA1347/084/003
Perindopril tert-butylamine, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Pomalidomide Krka 1 mg hard capsules
EU/1/24/1832/001-002
Pomalidomide Krka, d.d., Novo mesto
Pomalidomide Krka 2 mg hard capsules
EU/1/24/1832/003-004
Pomalidomide Krka, d.d., Novo mesto
Pomalidomide Krka 3 mg hard capsules
EU/1/24/1832/005-006
Pomalidomide Krka, d.d., Novo mesto
Pomalidomide Krka 4 mg hard capsules
EU/1/24/1832/007-008
Pomalidomide Krka, d.d., Novo mesto
Prasugrel Krka 10 mg Film-coated tablets
PA1347/080/002
Prasugrel KRKA, d.d., Novo mesto Not marketed
Prasugrel Krka 5 mg Film-coated tablets
PA1347/080/001
Prasugrel KRKA, d.d., Novo mesto Not marketed
Pregabalin Krka 100 mg hard capsules
PA1347/050/004
Pregabalin KRKA, d.d., Novo mesto Marketed
Pregabalin Krka 150 mg hard capsules
PA1347/050/005
Pregabalin KRKA, d.d., Novo mesto Marketed
Pregabalin Krka 200 mg hard capsules
PA1347/050/006
Pregabalin KRKA, d.d., Novo mesto Marketed
Pregabalin Krka 225 mg hard capsules
PA1347/050/007
Pregabalin KRKA, d.d., Novo mesto Not marketed
Pregabalin Krka 25mg hard capsules
PA1347/050/001
Pregabalin KRKA, d.d., Novo mesto Marketed
Pregabalin Krka 300 mg hard capsules
PA1347/050/008
Pregabalin KRKA, d.d., Novo mesto Marketed
2 3 4 5 6 7 8

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.